Potency estimates play a central role in drug development. It is imperative that orthogonal platforms to cell-based assays be established for cross validation as a complementary strategy directive per regulatory guidelines.

Download this application note to see how AlphaLISA® bead-based, homogeneous assays proves an ideal orthogonal approach to cell-based potency assays for a biotherapeutics system